文献速递妇科

子宫内膜癌中双体细胞错配修复基因致病变异与Lynch综合征同样常见

Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients.
PubMed 文献 · Gynecol Oncol · 2020-10-21

研究纳入341例子宫内膜癌患者,所有肿瘤行错配修复蛋白免疫组化、微卫星不稳定检测及MLH1甲基化检测,对缺乏MLH1甲基化的dMMR病例行胚系基因检测,未发现胚系致病变异者行肿瘤测序。结果显示dMMR病例中Lynch综合征与双体细胞MMR致病变异各占一部分,提示对非甲基化dMMR肿瘤行肿瘤与胚系配对检测可能是Lynch综合征筛查最有效的方式。

要点

  • dMMR子宫内膜癌中双体细胞MMR致病变异与Lynch综合征频率相当
  • 非甲基化dMMR肿瘤建议行肿瘤与胚系配对检测以筛查Lynch综合征
  • 多数dMMR肿瘤由MLH1甲基化解释

核心结论

  • 在子宫内膜癌患者中,双体细胞MMR基因致病变异与Lynch综合征同样常见。
  • 对非甲基化dMMR肿瘤患者行肿瘤与胚系配对检测可能是Lynch综合征筛查最有效的方式。

研究设计与样本

  • 所有肿瘤行四种MMR蛋白免疫组化染色、MSI检测,MMR缺陷肿瘤行MLH1甲基化检测。
  • 对缺乏MLH1甲基化的dMMR病例行Lynch综合征胚系基因检测,未发现胚系MMR基因致病变异者行肿瘤测序。

主要发现

  • dMMR病例中多数存在MLH1甲基化,为69例,占dMMR病例的75.8%、全部病例的20.2%。
  • 22例(6.5%)dMMR不能由甲基化解释,其中10例(全部病例的2.9%)为Lynch综合征(6例MSH6、3例MSH2、1例PMS2)。
  • 其余12例dMMR病例(全部病例的3.5%)由双体细胞MMR致病变异所致。

临床怎么用

  • 对子宫内膜癌患者可先行肿瘤MMR免疫组化与MSI检测,dMMR者检测MLH1甲基化。
  • 对缺乏MLH1甲基化的dMMR肿瘤,可考虑肿瘤与胚系配对检测以同时识别Lynch综合征与双体细胞MMR致病变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Lynch syndrome is the most common cause of inherited endometrial cancer, attributable to germline pathogenic variants (PV) in mismatch repair (MMR) genes. Tumor microsatellite instability (MSI-high) and MMR IHC abnormalities are characteristics of Lynch syndrome. Double somatic MMR gene PV also cause MSI-high endometrial cancers. The aim of this study was to determine the relative frequency of Lynch syndrome and double somatic MMR PV. METHODS: 341 endometrial cancer patients enrolled in the Ohio Colorectal Cancer Prevention Initiative at The Ohio State University Comprehensive Cancer Center from 1/1/13-12/31/16. All tumors underwent immunohistochemical (IHC) staining for the four MMR proteins, MSI testing, and MLH1 methylation testing if the tumor was MMR-deficient (dMMR). Germline genetic testing for Lynch syndrome was undertaken for all cases with dMMR tumors lacking MLH1 methylation. Tumor sequencing followed if a germline MMR gene PV was not identified. RESULTS: Twenty-seven percent (91/341) of tumors were either MSI-high or had abnormal IHC indicating dMMR. As expected, most dMMR tumors had MLH1 methylation; (69, 75.8% of the dMMR cases; 20.2% of total). Among the 22 (6.5%) cases with dMMR not explained by methylation, 10 (2.9% of total) were found to have Lynch syndrome (6 MSH6, 3 MSH2, 1 PMS2). Double somatic MMR PV accounted for the remaining 12 dMMR cases (3.5% of total). CONCLUSIONS: Since double somatic MMR gene PV are as common as Lynch syndrome among endometrial cancer patients, paired tumor and germline testing for patients with non-methylated dMMR tumor may be the most efficient approach for LS screening.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Hampel H, Pearlman R, de la Chapelle A, et al. Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients. Gynecol Oncol. 2020. PMID: 33393477. doi:10.1016/j.ygyno.2020.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。